Human decay accelerating factor successfully protects pig hearts from hyperacute rejection by human blood.
Schmoeckel
M
M
Department of Cardiac Surgery, Klinikum Grosshadern, University of Munich, Germany.
Nollert
G
G
Shahmohammadi
M
M
Young
V K
VK
Knig
W
W
White
D J
DJ
Hammer
C
C
Reichart
B
B
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000818:Animals; D030801:Animals, Genetically Modified; D001794:Blood Pressure; D018958:CD55 Antigens / Q000096:biosynthesis / Q000502:physiology*; D003402:Creatine Kinase / Q000097:blood; D015232:Dinoprostone / Q000097:blood; D004730:Endothelium, Vascular / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006321:Heart / Q000502:physiology*; D016027:Heart Transplantation; D006439:Hemodynamics; D006801:Humans; D010477:Perfusion; D013552:Swine
D018958:CD55 Antigens; D015121:6-Ketoprostaglandin F1 alpha; D003402:Creatine Kinase; D015232:Dinoprostone